Zenagamtide clinical trials

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

This study looks at a new diabetes drug, zenagamtide, compared to insulin glargine. It’s for people with type 2 diabetes who are already taking other diabetes medicines and are at a higher risk of heart and blood vessel problems. The aim is to see how well zenagamtide lowers blood sugar and body weight.